Actively Recruiting

Phase 3
Age: 18Years +
All Genders
NCT07261644

A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis(AS)

Led by Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · Updated on 2025-12-10

500

Participants Needed

1

Research Sites

105 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study will evaluate the efficacy and safety of 608 in patients with AS.

CONDITIONS

Official Title

A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis(AS)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Able to understand and comply with the protocol requirements, participate and sign the informed consent form (ICF) voluntarily
  • At least 18 years of age at the time of signing the ICF, with no gender restrictions
  • Meet the 1984 modified New York criteria for ankylosing spondylitis (AS)
  • Have inadequate response to non-steroidal anti-inflammatory drugs (NSAIDs) or have contraindications/intolerance to NSAIDs treatment
  • Willing to practice contraception and have no plans for pregnancy, sperm donation, or egg donation from the screening period until at least 6 months after the last dose.
Not Eligible

You will not qualify if you...

  • Patients with other uncontrolled active inflammatory diseases
  • Clinical laboratory tests and other tests that reveal abnormalities with clinical significance
  • Patients who have active Hepatitis B, Hepatitis C or HIV infections as determined by positive results at Screening
  • History of cancer
  • Known or suspected history of immunosuppression

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Site 01

Beijing, Beijing Municipality, China, 100730

Actively Recruiting

Loading map...

Research Team

Q

Qing hong Zhou

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here